BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2000
View Archived Issues
Company Profile: Bolder Biotechnology
Read More
Progenics begins phase II pediatric trial with PRO-542
Read More
All patients dosed in trial of long-acting inhaled formulation of albuterol for asthma
Read More
Deltagen obtains license to develop potential AML treatment
Read More
FDA grants orphan drug status for Eurogene's Trinam
Read More
FeRx and Elan to develop MTC-DOX for treatment of liver cancer
Read More
Company Profile: GenStar Therapeutics
Read More
R-102444, a prodrug-type 5-HT2 antagonist, as a promising candidate for thrombosis
Read More
Maxim receives SBIR grant for development of caspase-inducing drugs
Read More
Russian antiretroviral agent effective and well tolerated in the clinic
Read More
ArQule and SmithKline Beecham partner for drug discovery
Read More
PDL to humanize antibody for InterMune
Read More
Mechanism of action of thalidomide in Crohn's disease investigated as part of clinical trial
Read More
New target for IBD treatment discussed at UEGW: leukocyte-platelet aggregation
Read More
ProdiGene receives NIH grant for development of AIDS vaccine from transgenic plants
Read More
Micrologix initiates phase Ib study for drug candidate active against S. aureus
Read More
Secondary efficacy measures improved by ISIS-2302 treatment in Crohn's disease
Read More
Abgenix and CuraGen expand genomics-based antibody drug alliance
Read More
Nonimidazole histamine H3 antagonists with excellent oral activity in mouse brain
Read More
Antibiotic properties discovered for new aromatic amides synthesized at Aventis
Read More
Nitric oxide synthase inhibitors for inflammation and pain described by AstraZeneca
Read More
Vertex presents newest JNK protein kinase inhibitors in recent patent
Read More
Preparation and use of new azepinoindole 5-HT receptor ligands from Pharmacia
Read More
Ziprasidone pharmaceutical formulations with good solubility properties
Read More
U.K. scientists investigate novel series of antitumor agents
Read More
Scotia submits additional data to FDA for Foscan NDA
Read More
Imifuramine: synthesis of a novel histamine H3 receptor agonist
Read More
Novel H3 receptor agonists show full agonist activity in vivo after oral dosing
Read More